Author Archives: Scalper1

7 Steps To The Launching Of A National Debate On The Realities Of Stock Investing

By Rob Bennett Step One: The Buy-and-Holders Accept That a Debate Is Inevitable. This is a turf battle. Eugene Fama and Robert Shiller have both won Nobel prizes for saying opposite things about how stock investing works. It’s not possible that both are right. The natural thing would have been for the debate to have been launched in 1981, when Shiller published his “revolutionary” (his word) research findings. Things got held up because there is so much money to be made in this field, and by the time Shiller published his research, thousands of people had built careers promoting Buy-and-Hold strategies. These people were naturally not too excited about the idea of acknowledging that they had been giving bad advice for a long time. The reality is that sooner or later, they are going to have to at least acknowledge that possibility. A Nobel prize cannot be denied. And, if Shiller is right, the promotion of Buy-and-Hold strategies caused an economic crises. This affects everyone. So, the debate has to come. Once that is widely recognized, the question changes from whether or not to have the debate to how to proceed with the important business of launching it. Step Two: Industry Leaders Recognize How Much Money There Is to Be Made by Moving Forward. I often hear a cynical response when I make the case for the launching of a national debate. People say that there is too much money made promoting Buy-and-Hold for the industry to permit a debate that might discredit the strategy. I don’t think that’s right. Valuation-Informed Indexing reduces risk dramatically. Millions of middle-class people resist the lure of stocks because they are turned off by the idea of taking on too much risk with their retirement money. A transition to the Shiller model would increase profits for those in the stock-selling industry, not diminish them. The problem, for many years, has been that profits were good enough as a result of the huge bull market, and so, there was a feeling that there was no cause to rock the boat. The next price crash will change that. After prices fall hard again, the industry will be feeling the pinch and will go looking for ways to restore public confidence in the market. That’s when people will see that the model of the future has been available to us for 35 years – it’s just been a question of us developing an interest in taking advantage of the opportunity. Step Three: Jack Bogle Says “I’m Not Entirely Sure” Whether Fama or Shiller is Right. The debate has been delayed because the Buy-and-Hold Model was established first, and getting investing right is so important that the Buy-and-Holders have thus far not been able to acknowledge even the possibility of their having made a mistake. That changes on the day when Bogle says the words “I’m” and “Not” and “Sure” in a public place and his words are written up on the front page of the New York Times . Everyone who works in this field would interpret those words as giving them permission to talk openly about the case against Buy-and-Hold. Once there are people speaking openly, clearly and firmly on both sides of the story, we will all be engaged in an amazing learning experience. Step Four: Behavioral Finance Experts Seek to Distinguish Themselves By Drawing Sharp Contrasts Between Their Advice on Strategic Questions and the Advice Offered by the Buy-and-Holders. Behavioral Finance has been a growing field for many years. But it has had little impact in the practical realm, because the Behavioral Finance experts have shied away from showing how a model that considers the effect of human psychology on investing choices leads to very different advice on strategic questions (particularly, asset allocation questions). For so long as Buy-and-Hold has remained dominant, it has seemed “rude” to point out that the Buy-and-Hold advice on just about every question is dangerous if Shiller is right that valuations affect long-term returns and that risk is thus not static, but variable. Once the floodgates are opened by Bogle’s historic speech, each of the Behavioral Finance experts will tap into a healthy competitive instinct to distinguish himself or herself by showing how different his or her advice is from the conventional Buy-and-Hold advice. We will see 35 years of insights developed and explained and promoted and explored in the space of a few years. Exciting times! Step Five: Thought Leaders Recognize the Need to Help the Buy-and-Holders Save Face. We need to see a battle of ideas, not a battle of personalities. We want the Buy-and-Holders working with us, not against us. The Buy-and-Holders built the foundation on which Valuation-Informed Indexing is built. It would be as crazy for us to come to see them as enemies once the debate is launched as it has been for them to see us as enemies during the decades in which it has been delayed. Wise heads will prevail. We will see that we are all in this together. As a result, things will move ahead at a quick pace once things begin moving ahead. The Buy-and-Holders have a lot to contribute, and they will do so as long as we are careful to acknowledge their many genuine achievements. Step Six: The Political Implications of Shiller’s Breakthrough Come to Be More Widely Appreciated. It was the promotion of Buy-and-Hold strategies that caused the economic crisis (by encouraging stock prices to soar to insanely dangerous levels, and then by causing the economy to lose trillions of dollars of buying power when the bubble popped). The economic crisis affects all of us, not just the investing industry and not just those who buy stocks. The debate will go into high gear when it becomes widely understood that we all have a stake in ensuring that we all have access to sound, responsible and research-backed investing advice. The stock-selling industry has been dragging its feet for a long time. But this is bigger than the stock-selling industry. Step Seven: Outsiders Flood into the Stock-Selling Industry. The launching of the debate need not be perceived as a threat to those currently working in the field and promoting Buy-and-Hold strategies. But it will speed things up when initial discussion of the new model shows the need for the industry to welcome new types of experts. We will be seeing a transition from a focus on math-based skills to a focus on psychology-based skills. The new blood will bring the field alive (but we are, of course, always going to need lots of people with math-based skills in this field). Disclosure: None.

Facebook Passes 50-Day Test; Netflix, Illumina Break 2 Support Lines

Facebook ( FB ) tested a key level Tuesday morning but came out stronger. But Netflix ( NFLX ) and Illumina ( ILMN ) crashed through support levels on weak Q1 figures. IBM ( IBM ) gets an incomplete. MaxLinear ( MXL ) triggered a sell rule as well as breaking a support level. Facebook Facebook has been finding support at its 50-day moving average since April 11, when shares finished just below that key level. Since then the stock has closed above that support level. On Tuesday, Facebook shook off a morning dip to just above the 50-day to rally for a 1.7% gain at 112.29. On the upside, the next key level is a buy point at 117.09. Facebook releases earnings next week, with analysts expecting a 48% EPS gain, the third straight quarter of accelerating growth. Netflix Netflix late Monday reported an unexpected rise in Q1 earnings per share. Subscriber growth also topped expectations. But the Web-streaming giant expects net global-customer growth of just 2.5 million in Q2, which would be the weakest quarterly gain in two years . It also guided Q2 earnings lower. Netflix stock dived 13% Tuesday, crashing through its 200-day and 50-day moving averages in one fell swoop. (Netflix retook its 200-day line just last week). How do Netflix and IBM stack up vs. their rivals? Find out at IBD Stock Checkup Illumina Illumina late Monday gave Q1 preliminary revenue figures that were well below Wall Street estimates. The gene-sequencing tools giant sees Q1 sales up 6%, ending a 14-quarter string of double-digit growth. Illumina stock crashed 23.2% on Tuesday, back near two-year lows. Like Netflix, Illumina tumbled through its 200-day and 50-day lines. The stock on Monday topped its 200-day for the first time this year. IBM IBM revenue and earnings did top Wall Street forecasts late Monday, though sales have fallen for 16 straight quarters. Also, IBM’s implied Q2 EPS guidance appeared to be below analyst estimates. IBM stock fell 5.6% on Tuesday, undercutting its 200-day line intraday but closing just above that area. But IBM could easily retest the 200-day line in the coming days, with the 50-day only slightly below that. MaxLinear MaxLinear’s chip designs are used in video streaming. The stock cleared an entry point of 17.85 last month, rising to a 19.10 peak on April 4. But shares drifted lower since then. On Tuesday, the stock dived 10.2% to 15.86, triggering an 8% sell rule from that entry point and breaking through its 50-day moving average. It wasn’t immediately clear why the MaxLinear shares fell.

Here’s Why IBM Fell Despite A Solid Q1 Earnings Beat

IBM ( IBM ) closed down 5.6% at 144 Tuesday, following a first-quarter earnings report late Monday that beat estimates but still left room for concern. IBM has been undergoing a major transition, shedding older technologies while making a concerted push into growth areas such as cloud computing, Big Data analytics, security and mobile computing — areas it calls strategic imperatives. The transition helps explain why revenue growth has declined each quarter for the past four years. In its Q1 earnings results, IBM reported revenue of $18.7 billion, down 4.6% from the year-earlier quarter but edging the Wall Street consensus estimate of $18.3 billion. Revenue from strategic imperatives rose 14%. Total cloud revenue rose 34%. Earnings per share ex items of $2.35 easily beat views of $2.09, as polled by Thomson Reuters, but were down 19% and marked the fourth quarter in a row of EPS declines. IBM stock fell in the stock market today  presumably on the view that Q2 expectations are below estimates. IBM does not provide formal quarterly guidance, but its implied EPS guidance of $2.85 for Q2 is below the consensus estimate of 3.01. Despite the Q1 beat, IBM did not increase but instead maintained its full-year earnings outlook. IBD’s Take: How healthy is IBM’s stock and how does it stack up vs. rivals? Find out at IBD Stock Checkup RBC Capital Markets analyst Amit Daryanani maintained a sector perform rating on IBM stock, and a price target of 155. “We believe the competitive challenges are emerging from companies seeking to build a business model similar to IBM’s, notably Hewlett-Packard Enterprise ( HPE ), Cisco ( CSCO ), Oracle ( ORCL ), EMC ( EMC ), and Dell,” he wrote. Of these competitors, he said, Hewlett-Packard is the closest. Another is Cisco. ‘Attempting To Recreate The IBM Model’ “Beyond Hewlett-Packard and Cisco, there are also others attempting to recreate the IBM model,” he wrote. A harsher report on IBM came from Credit Suisse analyst Kulbinder Garcha, who reiterated an underperform rating and a price target of 110 on IBM stock. “We believe the quality of earnings was again low and the manner in which IBM has chosen to manage its business seems unsustainable,” Garcha wrote. “We believe the secular and structural challenges facing IBM remain, and specifically see limited improvement in Services and Software margins.” UBS analyst Steven Milunovich maintained a neutral rating on IBM but raised his price target to 150 from 132. “The quarter was mixed with revenue and EPS beating due to currency improvement, acquisitions, and the Japan tax rebate,” he wrote. “We give IBM credit for changing the narrative,” with an emphasis on becoming a leader in the new category of Cognitive Computing, which includes its Watson computer business, he wrote. Drexel Hamilton raised its revenue forecast, maintained its EPS projection and raised the price target to 166 from 160.